YKYa. V. Kulikovskikh

Ya. V. Kulikovskikh

*This is an algorithmically generated author record based on publicly available information.

Ya. V. Kulikovskikh has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endovascular embolization in the surgical treatment of renal angiomyolipoma

    by D. S. Luzhanskiy, I. A. . Aboyan, S. P. Semitko, Yа. V. Kulikovskikh, S. M. Pakus, T. Yu. Luneva, S. V. Ten, Д. С. Лужанский, И. А. Абоян, С. П. Семитко, et al.

    Introduction. Angiomyolipoma (AML) is the most common benign renal tumor. Selective arterial embolization of AML-feeding vessels is currently regarded as an effective organ-preserving treatment. However, the absence of unified criteria for predicting procedural success limits its widespread adoption. Objective. To evaluate the outcomes of endovascular embolization of renal AML according to tumor angioarchitectonic type. Materials & methods. This retrospective study included 30 patients with renal AML who underwent endovascular embolization between 2021 and 2024. Based on angiographic findings, all AMLs were classified into three types according to their vascular supply: type I (poor vascularization), type II (up to two major feeding arteries), and type III (multiple feeding arteries). Embolization was performed in patients with type II and III vascular patterns. Technical success of embolization, as well as changes in tumor size and volume at 6 and 12 months, were assessed. Results. The distribution of AMLs by vascular type was as follows: type I in 5 (17%) patients, type II in 16 (53%), and type III in 9 (30%). Embolization was technically not feasible in type I. Overall embolization success was achieved in 88% of cases (22 patients). Technical success was 100% for type II (16/16) versus 66.7% for type III (6/9). Statistical analysis demonstrated that the probability of successful embolization was 3.67 times higher for type II compared with type III (OR 3.67; 95% CI 1.85–7.26; p = 0.014). In all cases of successful embolization, a significant reduction in AML size and volume was observed during long-term follow-up. Conclusion. Selective embolization is an effective treatment for renal AML, achieving substantial tumor shrinkage. The proposed classification of AML vascular types is a clinically useful tool that allows stratification of patients by likelihood of technical success at the diagnostic angiography stage. The best embolization outcomes were observed in patients with type II angioarchitecture.

  • Open Access

    Intravascular ultrasound-guided renal artery stenting without the use of radiocontrast agents

    by I. A. Aboyan, Y. V. Kulikovskikh, N. V. Kalaitanova, R. H. Mkrtchyan, D. S. Luzhanskyi, D. V. Lavnik, D. S. Strokov, L. G. Oganesyan, M. Z. Gasanov, И. А. Абоян, et al.

    Aim . To analyze immediate and in-hospital outcomes of intravascular ultrasound (IVUS)-guided renal artery (RA) stenting without the use of radiocontrast agents in patients with chronic kidney disease (CKD) and renovascular hypertension. Material and methods . This prospective single-center study included 26 patients with CKD stage C3a-C5 and hemodynamically significant RA stenosis based on triplex ultrasound imaging. The patient age (median [min-max]) was 63 [48-76] years; 61,5% were women. Before the procedure, the median glomerular filtration rate (GFR) was 24 [1447] ml/min/1,73 m2, and creatinine — 287 [184-390] μmol/L. A total of 96,2% of patients had refractory hypertension, and 3,8% had a high renal dysfunction rate. All stages of the intervention were performed entirely under IVUS guidance. Technical success of the procedure, perioperative complications, and the incidence of any major adverse events during the hospital stay were assessed. Systolic blood pressure, serum creatinine, and eGFR were analyzed at discharge. Results. In two patients, IVUS revealed hemodynamically insignificant RA stenosis, therefore, stenting was not performed. The technical success of stenting was 100%. In 23 patients, the procedure was performed entirely without the use of a radiocontrast agent. In one patient, due to the specific RA involvement, ultra-low contrast administration was used. Following the intervention, the study group experienced a significant decrease in systolic blood pressure from 210 [140-260] to 130 [100-170] mm Hg (pConclusion . IVUS-guided RA stenting in patients with CKD stage C3a-C5 without the use of radiocontrast agents is technically feasible, effective, and safe. This technique can be considered a promising alternative to traditional approaches in carefully selected patients with contraindications to the use of radiocontrast agents.

  • Open Access

    Long-term echocardiography results in patients with ST-segment elevation myocardial infarction after pharmaco-invasive reperfusion therapy, depending on the choice of thrombolytic drug

    by A. V. Khripun, A. A. Кastanayan, M. V. Malevannyy, Ya. V. Kulikovskikh, Я. В. Куликовских

    Objectives: to analyze the results of echocardiography 1 year after STEMI in patients undergoing pharmaco-invasive reperfusion using various thrombolytic drugs.Materials and Methods: 240 patients with STEMI after pharmaco-invasive reperfusion were included in an open-label prospective cohort study. Depending on the thrombolytic agent used, the patients were divided into 4 groups: in the 1st (n = 73) — lysis was performed with alteplase; in the 2nd (n = 40) — tenecteplase; in the 3rd (n = 95) — forteplase; in the 4th (n = 32) — streptokinase. Depending on the fibrin-specificity of the thrombolytic, all patients were presented with 2 groups: the group of fibrin-specific thrombolytics (FST, n = 208) and the group of fibrin-nonspecific streptokinase (FNST, n = 32). Echocardiography was assessed 1 year after reperfusion.Results: after 1 year, there was a slight violation of the global LV systolic function, while the EF between the groups did not differ (p = 0.420). A higher EF was recorded in the FST group compared with FNST (49.8 ± 7.4 % versus 47.4 ± 6.8 %; p = 0.048). After 1 year, violations and local LV contractility persisted in each of the four groups (p = 0.161). At the same time, lower WMSI were recorded in the FST group compared to FNST (1.19 [1.06; 1.38] versus 1.25 [1.175; 1.5]; p = 0.029). In the FST group, significantly lower iEDV were recorded (p = 0.048), and iESV (p = 0.022) and LA size (p = 0.007) compared with FNST. In dynamics, 1 year after reperfusion in the FST group, there was a significant increase in EF by 5.5 % (p = 0.000) and a decrease in LV WMSI by 5 % (p = 0.000) compared with the FNST group.Conclusions: pharmaco-invasive treatment of STEMI with the use of thrombolytic drugs after 1 year of follow-up is characterized by comparable echocardiography parameters. After 1 year of follow-up, patients undergoing pharmaco-invasive treatment with fibrin-specific drugs had significantly higher EF, as well as lower WMSI, iEDV, iESV, and LA size compared to fibrin-nonspecific streptokinase.